FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:2276-2277 May 22, 2008 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

For many years, the editors of the Journal have relied on peer review to ensure the scientific quality of the articles that we publish. Of the thousands of manuscripts submitted to the Journal each year, we publish about 1 in 20. To aid us in selecting those manuscripts, we seek advice from thousands of peer reviewers. Confidential peer review is a key component of our manuscript selection process.

We were therefore concerned when in May 2007 lawyers for the pharmaceutical company Pfizer served us with a subpoena demanding that the Journal produce peer-review and other editorial documents on all manuscripts . . . [Full Text of this Article]

Source Information

From the Department of Health Law, Bioethics, and Human Rights, Boston University School of Public Health, Boston (G.J.A.).

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.